These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35886191)

  • 1. Sacral Neuromodulation in Pregnant Women-A Case Report and Literature Review.
    Szymański JK; Słabuszewska-Jóźwiak A; Jakiel G
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder.
    Oelke M; Addali M; Reisenauer C
    Arch Gynecol Obstet; 2019 May; 299(5):1243-1252. PubMed ID: 30941558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active sacral neuromodulator during pregnancy: a unique case report.
    Mamopoulos A; Stavrakis T; Mavromatidis G; Rousso D
    Am J Obstet Gynecol; 2014 Jul; 211(1):e4-5. PubMed ID: 24732000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration of a sacral neuromodulation electrode after vaginal delivery in a female patient with non-obstructive urinary retention.
    El-Akri M; Peyronnet B
    Fr J Urol; 2024 Jun; 34(6):102605. PubMed ID: 38431080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral Neuromodulation: Device Improvement and Current Applications in Urology.
    Spilotros M; Gerbasi S; Lasorsa F; de Rienzo G; Balducci L; Ditonno P; Lucarelli G
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sacral neuromodulation effective and safe in pregnancy? A systematic review.
    Salehi-Pourmehr H; Atayi M; Mahdavi N; Aletaha R; Kashtkar M; Sharifimoghadam S; Hassanzadeh R; Hajebrahimi S
    Neurourol Urodyn; 2023 Aug; 42(6):1329-1343. PubMed ID: 37288591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
    Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
    Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
    Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
    Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
    Tahseen S
    Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
    Amin K; Moskowitz D; Kobashi KC; Lee UJ; Lucioni A
    J Urol; 2019 May; 201(5):973-978. PubMed ID: 30694936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors in Sacral Neuromodulation: A Systematic Review.
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; Vrijens D; van Kerrebroeck P
    Urol Int; 2022; 106(4):323-343. PubMed ID: 34058731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does age alone negatively predict the outcome of sacral neuromodulation? A single-centre retrospective observational study.
    Schönburg S; Bukethal T; Fornara P
    BMC Urol; 2020 May; 20(1):55. PubMed ID: 32410612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.
    Hoag N; Plagakis S; Pillay S; Edwards AW; Gani J
    Neurourol Urodyn; 2017 Jun; 36(5):1377-1381. PubMed ID: 27612039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
    Fletcher N
    Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
    Tilborghs S; De Wachter S
    Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.